Immunotherapy of COVID-19: inside and beyond IL-6 signalling
G Zizzo, A Tamburello, L Castelnovo, A Laria… - Frontiers in …, 2022 - frontiersin.org
Acting on the cytokine cascade is key to preventing disease progression and death in
hospitalised patients with COVID-19. Among anti-cytokine therapies, interleukin (IL)-6 …
hospitalised patients with COVID-19. Among anti-cytokine therapies, interleukin (IL)-6 …
Autophagy in health and disease: From molecular mechanisms to therapeutic target
Macroautophagy/autophagy is an evolutionally conserved catabolic process in which
cytosolic contents, such as aggregated proteins, dysfunctional organelle, or invading …
cytosolic contents, such as aggregated proteins, dysfunctional organelle, or invading …
[PDF][PDF] Retracted: meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection
A Hill, A Garratt, J Levi, J Falconer, L Ellis… - Open Forum …, 2021 - academic.oup.com
Ivermectin is an antiparasitic drug being investigated for repurposing against severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Ivermectin showed in vitro activity …
respiratory syndrome coronavirus 2 (SARS-CoV-2). Ivermectin showed in vitro activity …
[HTML][HTML] Коронавирусная болезнь 2019 (COVID-19) и иммуновоспалительные ревматические заболевания. Рекомендации Общероссийской общественной …
ЕЛ Насонов, АМ Лила, ВИ Мазуров… - Научно …, 2021 - cyberleninka.ru
В середине 2021 года инфекция SARS-CoV-2 (Severe Acute Respiratory coronavirus 2),
вызвавшая пандемию коронавирусной болезни 2019 (coronavirus disease, COVID-19) …
вызвавшая пандемию коронавирусной болезни 2019 (coronavirus disease, COVID-19) …
Efficacy and safety of azithromycin in Covid‐19 patients: A systematic review and meta‐analysis of randomized clinical trials
Azithromycin (AZM) is commonly used in Covid‐19 patients based on low‐quality evidence,
increasing the risk of developing adverse events and antimicrobial resistance. The current …
increasing the risk of developing adverse events and antimicrobial resistance. The current …
Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease
M AlQahtani, N Kumar, D Aljawder, A Abdulrahman… - Scientific Reports, 2022 - nature.com
Favipiravir has antiviral activity against influenza, West Nile virus, and yellow fever virus and
against flaviviruses. The objective of this pilot study was to compare three arms: favipiravir; …
against flaviviruses. The objective of this pilot study was to compare three arms: favipiravir; …
Systematic review and meta-analysis of ivermectin for treatment of COVID-19: evidence beyond the hype
MS Marcolino, KC Meira, NS Guimarães… - BMC Infectious …, 2022 - Springer
Background The role of ivermectin in the treatment of COVID-19 is still under debate, yet the
drug has been widely used in some parts of the world, as shown by impressive market data …
drug has been widely used in some parts of the world, as shown by impressive market data …
[HTML][HTML] Коронавирусная болезнь 2019 (COVID-19) и аутоиммунитет
ЕЛ Насонов - Научно-практическая ревматология, 2021 - cyberleninka.ru
Пандемия коронавирусной болезни 2019 (coronavirus disease, COVID-19),
этиологически связанной с вирусом SARS-CoV-2 (severe acute respiratory syndrome …
этиологически связанной с вирусом SARS-CoV-2 (severe acute respiratory syndrome …
Consumption trends of antibiotics in Brazil during the COVID-19 pandemic
FS Del Fiol, CC Bergamaschi… - Frontiers in …, 2022 - frontiersin.org
Background: In 2019, a new type of coronavirus emerged and spread to the rest of the world.
Numerous drugs were identified as possible treatments. Among the candidates for possible …
Numerous drugs were identified as possible treatments. Among the candidates for possible …
Autophagy-inflammation interplay during infection: Balancing pathogen clearance and host inflammation
Y Pang, L Wu, C Tang, H Wang, Y Wei - Frontiers in Pharmacology, 2022 - frontiersin.org
Inflammation is an essential immune response of the host against infections but is often over-
activated, leading to a variety of disorders. Autophagy, a conserved degradation pathway …
activated, leading to a variety of disorders. Autophagy, a conserved degradation pathway …